Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9320774
APP PUB NO 20150202254A1
SERIAL NO

14262512

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for reducing the radio-resistance of prostate cancer cells in a subject in need thereof, comprising administering to the subject an effective amount of an active component, wherein the active component is a nanoparticle of a carrier encapsulated with cytolethal distending toxin subunit B (CdtB).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHINA MEDICAL UNIVERSITYTAICHUNG 40402

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, Chia-Shuo Taichung, TW 1 0
Lai, Cheng-Kuo Taichung, TW 1 0
Lai, Chih-Ho Taichung, TW 10 1
Lin, Yu-Hsin Taichung, TW 187 659

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 26, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00